Friday, October 16, 2020 9:17:32 AM
"The Covid study is moving forward with incredible velocity. We expect to read out the Phase three trial by the end of the year. But, two weeks from now, there's going to be a meeting of the data safety monitoring board (DSMB). And they're going to review the first 102 patients in the trial. They have the potential to see both futility, which we hope they won't see, or perhaps they will see overwhelming evidence of efficacy. Either, which would lead to STOPPING THE TRIAL."
I don't know about you, but I get the sense Javitt is expecting them to stop the trial at the DSMB meeting, due to "overwhelming evidence of efficacy".
QUESTIONS:
Does anyone know exactly what day that meeting is?
Also... do we think that is the day they will actually stop the trail and make the announcement... OR... is that the day they make the decision and then would need some additional time to prepare the data for an official announcement?
(Trying to nail down a realistic date we should expect to find out the verdict.)
Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM